Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Collective cancer invasion forms an integrin-dependent radioresistant niche.

Haeger A, Alexander S, Vullings M, Kaiser FMP, Veelken C, Flucke U, Koehl GE, Hirschberg M, Flentje M, Hoffman RM, Geissler EK, Kissler S, Friedl P.

J Exp Med. 2019 Oct 28. pii: jem.20181184. doi: 10.1084/jem.20181184. [Epub ahead of print]

PMID:
31658985
2.

Anti-BAFF treatment interferes with humoral responses in a model of renal transplantation in rats.

Steines L, Poth H, Schuster A, Geissler EK, Amann K, Banas B, Bergler T.

Transplantation. 2019 Oct 11. doi: 10.1097/TP.0000000000002992. [Epub ahead of print]

PMID:
31609901
3.

Randomized Sirolimus-based early calcineurin inhibitor reduction in liver transplantation: impact on renal function.

Buchholz BM, Ferguson JW, Schnitzbauer AA, Nightingale P, Schlitt HJ, Geissler EK, Mirza DF; and the International SiLVER study group.

Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002980. [Epub ahead of print]

PMID:
31577671
4.

Oxygen levels during negative pressure wound therapy.

Biermann N, Geissler EK, Brix E, Schiltz D, Prantl L, Kehrer A, Taeger CD.

J Tissue Viability. 2019 Sep 4. pii: S0965-206X(19)30087-7. doi: 10.1016/j.jtv.2019.09.001. [Epub ahead of print]

PMID:
31500929
5.

Potential Use of Gluconate in Cancer Therapy.

Mycielska ME, Mohr MTJ, Schmidt K, Drexler K, Rümmele P, Haferkamp S, Schlitt HJ, Gaumann A, Adamski J, Geissler EK.

Front Oncol. 2019 Jun 19;9:522. doi: 10.3389/fonc.2019.00522. eCollection 2019.

6.

IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils.

Balam S, Schiechl-Brachner G, Buchtler S, Halbritter D, Schmidbauer K, Talke Y, Neumayer S, Salewski JN, Winter F, Karasuyama H, Yamanishi Y, Renner K, Geissler EK, Mack M.

J Immunol. 2019 Jun 15;202(12):3514-3523. doi: 10.4049/jimmunol.1801269. Epub 2019 May 8.

PMID:
31068389
7.

Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective.

Ten Brinke A, Martinez-Llordella M, Cools N, Hilkens CMU, van Ham SM, Sawitzki B, Geissler EK, Lombardi G, Trzonkowski P, Martinez-Caceres E.

Front Immunol. 2019 Feb 22;10:181. doi: 10.3389/fimmu.2019.00181. eCollection 2019. Review.

8.

Can Mycophenolic Acid-based Immunosuppression Benefit Liver Transplant Patients With HCC?

Geissler EK, Schlitt HJ.

Transplantation. 2019 May;103(5):873-874. doi: 10.1097/TP.0000000000002648. No abstract available.

PMID:
30720687
9.

The Authors' Reply.

Proneth A, Geissler EK, Schlitt HJ, Farkas SA.

Transplantation. 2018 Dec;102(12):e495. doi: 10.1097/TP.0000000000002439. No abstract available.

PMID:
30461729
10.

Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.

Schmidt KM, Dietrich P, Hackl C, Guenzle J, Bronsert P, Wagner C, Fichtner-Feigl S, Schlitt HJ, Geissler EK, Hellerbrand C, Lang SA.

Neoplasia. 2018 Dec;20(12):1198-1208. doi: 10.1016/j.neo.2018.10.001. Epub 2018 Nov 4.

11.

C5aR1 governs Mreg migration, development, and function.

Riquelme P, Geissler EK, Hutchinson JA.

Am J Transplant. 2019 Mar;19(3):619-621. doi: 10.1111/ajt.15153. Epub 2018 Nov 26. No abstract available.

PMID:
30372590
12.

Murine DX5+NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4+CD62Lhigh T Cells through Fas Ligand.

Werner JM, Damian M, Farkas SA, Schlitt HJ, Geissler EK, Hornung M.

J Immunol Res. 2018 Sep 30;2018:8175810. doi: 10.1155/2018/8175810. eCollection 2018.

13.

Reply to "How Far can we Expand Donor Age Criteria for Pancreas Transplantation?"

Proneth A, Geissler EK, Schlitt HJ, Farkas SA.

Transplantation. 2018 Sep 4. doi: 10.1097/TP.0000000000002439. [Epub ahead of print] No abstract available.

PMID:
30188412
14.

Extracellular Citrate and Cancer Metabolism-Response.

Mycielska ME, Geissler EK.

Cancer Res. 2018 Sep 1;78(17):5177. doi: 10.1158/0008-5472.CAN-18-1899. Epub 2018 Aug 16. No abstract available.

15.

TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity.

Riquelme P, Haarer J, Kammler A, Walter L, Tomiuk S, Ahrens N, Wege AK, Goecze I, Zecher D, Banas B, Spang R, Fändrich F, Lutz MB, Sawitzki B, Schlitt HJ, Ochando J, Geissler EK, Hutchinson JA.

Nat Commun. 2018 Jul 20;9(1):2858. doi: 10.1038/s41467-018-05167-8.

16.

Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response.

Göcze I, Ehehalt K, Zeman F, Riquelme P, Pfister K, Graf BM, Bein T, Geissler EK, Kasprzak P, Schlitt HJ, Kellum JA, Hutchinson JA, Eggenhofer E, Renner P.

Crit Care. 2018 Jul 4;22(1):168. doi: 10.1186/s13054-018-2094-x.

17.

Immunological investigations empower transplant drug trials.

Geissler EK, Hutchinson JA.

Lancet. 2018 Jun 30;391(10140):2578-2579. doi: 10.1016/S0140-6736(18)31081-X. Epub 2018 Jun 14. No abstract available.

PMID:
29910041
18.

European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation.

Ahrens N, Geissler EK, Witt V, Berneburg M, Wolff D, Hirt SW, Banas B, Schlitt HJ, Hutchinson JA.

Transplantation. 2018 Aug;102(8):1279-1283. doi: 10.1097/TP.0000000000002244. No abstract available.

PMID:
29664769
19.

Selenium-binding protein 1 is down-regulated in malignant melanoma.

Schott M, de Jel MM, Engelmann JC, Renner P, Geissler EK, Bosserhoff AK, Kuphal S.

Oncotarget. 2018 Jan 2;9(12):10445-10456. doi: 10.18632/oncotarget.23853. eCollection 2018 Feb 13.

20.

Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo.

Mycielska ME, Dettmer K, Rümmele P, Schmidt K, Prehn C, Milenkovic VM, Jagla W, Madej GM, Lantow M, Schladt M, Cecil A, Koehl GE, Eggenhofer E, Wachsmuth CJ, Ganapathy V, Schlitt HJ, Kunzelmann K, Ziegler C, Wetzel CH, Gaumann A, Lang SA, Adamski J, Oefner PJ, Geissler EK.

Cancer Res. 2018 May 15;78(10):2513-2523. doi: 10.1158/0008-5472.CAN-17-2959. Epub 2018 Mar 6.

21.

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.

Hutchinson JA, Weigand K, Adenugba A, Kronenberg K, Haarer J, Zeman F, Riquelme P, Hornung M, Ahrens N, Schlitt HJ, Geissler EK, Werner JM.

Front Immunol. 2018 Feb 7;9:146. doi: 10.3389/fimmu.2018.00146. eCollection 2018.

22.

Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years.

Proneth A, Schnitzbauer AA, Schenker P, Wunsch A, Rauchfuss F, Arbogast H, Manekeller S, Nadalin S, Heise M, Ströhlein MA, Banas B, Schemmer P, Becker T, Bechstein WO, Pascher A, Viebahn R, Geissler EK, Schlitt HJ, Farkas SA.

Transplantation. 2018 Aug;102(8):1330-1337. doi: 10.1097/TP.0000000000002122.

PMID:
29406443
23.

Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function.

Ribechini E, Hutchinson JA, Hergovits S, Heuer M, Lucas J, Schleicher U, Jordán Garrote AL, Potter SJ, Riquelme P, Brackmann H, Müller N, Raifer H, Berberich I, Huber M, Beilhack A, Lohoff M, Bogdan C, Eyrich M, Hermanns HM, Geissler EK, Lutz MB.

Blood Adv. 2017 Jun 7;1(14):947-960. doi: 10.1182/bloodadvances.2017006858. eCollection 2017 Jun 13.

24.

Bile duct regeneration and immune response by passenger lymphocytes signals biliary recovery versus complications after liver transplantation.

Junger HH, Schlitt HJ, Geissler EK, Fichtner-Feigl S, Brunner SM.

Liver Transpl. 2017 Nov;23(11):1422-1432. doi: 10.1002/lt.24836.

25.

DHRS9 Is a Stable Marker of Human Regulatory Macrophages.

Riquelme P, Amodio G, Macedo C, Moreau A, Obermajer N, Brochhausen C, Ahrens N, Kekarainen T, Fändrich F, Cuturi C, Gregori S, Metes D, Schlitt HJ, Thomson AW, Geissler EK, Hutchinson JA.

Transplantation. 2017 Nov;101(11):2731-2738. doi: 10.1097/TP.0000000000001814.

26.

MITAP-compliant characterization of human regulatory macrophages.

Hutchinson JA, Ahrens N, Geissler EK.

Transpl Int. 2017 Aug;30(8):765-775. doi: 10.1111/tri.12988. Epub 2017 Jun 26. Review.

27.

Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models.

Schmidt KM, Hellerbrand C, Ruemmele P, Michalski CW, Kong B, Kroemer A, Hackl C, Schlitt HJ, Geissler EK, Lang SA.

Oncotarget. 2017 Apr 11;8(15):24491-24505. doi: 10.18632/oncotarget.15524.

28.

Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.

Seebauer CT, Brunner S, Glockzin G, Piso P, Ruemmele P, Schlitt HJ, Geissler EK, Fichtner-Feigl S, Kesselring R.

Oncoimmunology. 2016 Oct 14;5(12):e1242543. doi: 10.1080/2162402X.2016.1242543. eCollection 2016.

29.

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment.

Renner K, Singer K, Koehl GE, Geissler EK, Peter K, Siska PJ, Kreutz M.

Front Immunol. 2017 Mar 8;8:248. doi: 10.3389/fimmu.2017.00248. eCollection 2017. Review.

30.

ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases.

Joechle K, Moser C, Ruemmele P, Schmidt KM, Werner JM, Geissler EK, Schlitt HJ, Lang SA.

World J Surg Oncol. 2017 Mar 7;15(1):57. doi: 10.1186/s12957-017-1121-8.

31.

Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.

Wadström J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Serón D, Grinyó J, Loupy A, Kuypers D, Mariat C, Clancy M, Jardine AG, Guirado L, Fellström B, O'Grady J, Pirenne J, O'Leary JG, Aluvihare V, Trunečka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M, Gray M.

Transplantation. 2017 Feb;101 Suppl 2S:S1-S41. doi: 10.1097/TP.0000000000001563. No abstract available.

PMID:
28125449
32.

Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture.

Hutchinson JA, Riquelme P, Bach C, Kekarainen T, Fändrich F, Geissler EK, Ahrens N.

Transplantation. 2017 May;101(5):e188-e190. doi: 10.1097/TP.0000000000001652. No abstract available.

PMID:
28114172
33.

Subcutaneous Murine Xenograft Models: A Critical Tool for Studying Human Tumor Growth and Angiogenesis In Vivo.

Schmidt KM, Geissler EK, Lang SA.

Methods Mol Biol. 2016;1464:129-137.

PMID:
27858362
34.

First Publication of Standardized Immune Monitoring Methods From the Virtual Global Transplantation Laboratory Initiative.

Geissler EK.

Transplant Direct. 2016 Aug 18;2(9):e100. eCollection 2016 Sep. No abstract available.

35.

LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M.

Cell Metab. 2016 Nov 8;24(5):657-671. doi: 10.1016/j.cmet.2016.08.011. Epub 2016 Sep 15.

36.

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.

Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, Ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van Kooten C, Lopez Diaz de Cerio A, Nikolic T, Oral HB, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres EM, Hilkens CMU.

PeerJ. 2016 Aug 30;4:e2300. doi: 10.7717/peerj.2300. eCollection 2016.

37.

Laser Ablation Inductively Coupled Plasma Mass Spectrometry: An Emerging Technology for Multiparametric Analysis of Tissue Antigens.

Hutchinson RW, McLachlin KM, Riquelme P, Haarer J, Broichhausen C, Ritter U, Geissler EK, Hutchinson JA.

Transplant Direct. 2015 Sep 25;1(8):e32. doi: 10.1097/TXD.0000000000000541. eCollection 2015 Sep.

38.

The Authors' Reply.

Geissler EK, Schnitzbauer AA, Schlitt HJ; SiLVER Study Group.

Transplantation. 2016 Aug;100(8):e44-5. doi: 10.1097/TP.0000000000001255. No abstract available.

PMID:
27362305
39.

Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.

Haarer J, Riquelme P, Hoffmann P, Schnitzbauer A, Schlitt HJ, Sawitzki B, Geissler EK, Hutchinson JA.

Transplantation. 2016 Jul;100(7):e39-40. doi: 10.1097/TP.0000000000001190. No abstract available.

PMID:
27326814
40.

IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3.

Kesselring R, Glaesner J, Hiergeist A, Naschberger E, Neumann H, Brunner SM, Wege AK, Seebauer C, Köhl G, Merkl S, Croner RS, Hackl C, Stürzl M, Neurath MF, Gessner A, Schlitt HJ, Geissler EK, Fichtner-Feigl S.

Cancer Cell. 2016 May 9;29(5):684-696. doi: 10.1016/j.ccell.2016.03.014. Epub 2016 Apr 14.

41.

Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?

Geissler EK, Schnitzbauer AA, Schlitt HJ; SiLVER Study Group.

Liver Transpl. 2016 Aug;22(8):1162-3. doi: 10.1002/lt.24464. Epub 2016 Jul 11. No abstract available.

42.

Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development.

Schiechl G, Hermann FJ, Rodriguez Gomez M, Kutzi S, Schmidbauer K, Talke Y, Neumayer S, Goebel N, Renner K, Brühl H, Karasuyama H, Obata-Ninomiya K, Utpatel K, Evert M, Hirt SW, Geissler EK, Fichtner-Feigl S, Mack M.

Am J Transplant. 2016 Sep;16(9):2574-88. doi: 10.1111/ajt.13764. Epub 2016 Mar 28.

43.

Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.

Rovira J, Renner P, Sabet-Baktach M, Eggenhofer E, Koehl GE, Lantow M, Lang SA, Schlitt HJ, Campistol JM, Geissler EK, Kroemer A.

Am J Transplant. 2016 Apr;16(4):1139-47. doi: 10.1111/ajt.13597. Epub 2016 Feb 8.

44.

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort.

Ten Brinke A, Hilkens CM, Cools N, Geissler EK, Hutchinson JA, Lombardi G, Lord P, Sawitzki B, Trzonkowski P, Van Ham SM, Martinez-Caceres EM.

Mediators Inflamm. 2015;2015:471719. doi: 10.1155/2015/471719. Epub 2015 Dec 24. Review.

45.

Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.

Schmidt K, Moser C, Hellerbrand C, Zieker D, Wagner C, Redekopf J, Schlitt HJ, Geissler EK, Lang SA.

Anticancer Res. 2015 Dec;35(12):6655-65.

PMID:
26637881
46.

Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma.

Renner P, Schuhbaum J, Kroemer A, Zeman F, Loss M, Lang SA, Geissler EK, Schlitt HJ, Farkas SA.

Langenbecks Arch Surg. 2016 Feb;401(1):43-53. doi: 10.1007/s00423-015-1359-y. Epub 2015 Dec 1.

PMID:
26627084
47.

Extracellular Citrate in Health and Disease.

Mycielska ME, Milenkovic VM, Wetzel CH, Rümmele P, Geissler EK.

Curr Mol Med. 2015;15(10):884-91. Review.

PMID:
26592250
48.

The Authors Reply.

Hutchinson JA, Geissler EK.

Kidney Int. 2015 Nov;88(5):1197. doi: 10.1038/ki.2015.265. No abstract available.

49.

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, Burra P, Jauch KW, Rentsch M, Ganten TM, Schmidt J, Settmacher U, Heise M, Rossi G, Cillo U, Kneteman N, Adam R, van Hoek B, Bachellier P, Wolf P, Rostaing L, Bechstein WO, Rizell M, Powell J, Hidalgo E, Gugenheim J, Wolters H, Brockmann J, Roy A, Mutzbauer I, Schlitt A, Beckebaum S, Graeb C, Nadalin S, Valente U, Turrión VS, Jamieson N, Scholz T, Colledan M, Fändrich F, Becker T, Söderdahl G, Chazouillères O, Mäkisalo H, Pageaux GP, Steininger R, Soliman T, de Jong KP, Pirenne J, Margreiter R, Pratschke J, Pinna AD, Hauss J, Schreiber S, Strasser S, Klempnauer J, Troisi RI, Bhoori S, Lerut J, Bilbao I, Klein CG, Königsrainer A, Mirza DF, Otto G, Mazzaferro V, Neuhaus P, Schlitt HJ.

Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965.

50.

Post-transplantation malignancies: here today, gone tomorrow?

Geissler EK.

Nat Rev Clin Oncol. 2015 Dec;12(12):705-17. doi: 10.1038/nrclinonc.2015.186. Epub 2015 Oct 20. Review.

PMID:
26483298

Supplemental Content

Loading ...
Support Center